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ABSTRACT
Gastroesophageal reflux disease has different clinical
presentations that require different diagnostic and thera-
peutic approaches. This paper describes the appropriate
use of diagnostic tests before and after treatment. Each
diagnostic tool is examined from a practical point of view
to determine the information it can provide and its pos-
sible pitfalls, and to comment on how it can influence
therapeutic choices. Performing a preoperative diagnos-
tic evaluation is especially stressed, so as not to select the
wrong patient or the wrong procedure. Finally, failures
of surgery are examined to understand their causes and
to prevent them. The value of the most relevant exami-
nations for diagnosing the causes of failures and choos-
ing the appropriate solution are discussed.
Key Words: Gastroesophageal reflux disease (GERD),
Esophageal pH monitoring, Esophageal manometry,
Antireflux surgery, Laparoscopic fundoplication,
Dysphagia.
INTRODUCTION
Everybody has gastroesophageal refluxes, especially
after a meal, but they are not very frequent, they rarely
last more than 5 minutes, rarely occur at night, the total
duration does not exceed about 1 hour a day, and symp-
toms are absent or occasional. Gastroesophageal reflux
disease (GERD) is a very common syndrome, but most
patients have mild symptoms, do not seek medical atten-
tion, and medicate themselves with antiacids when need-
ed. Medical aid is sought when the clinical setting is
more important. Of course, the boundaries between dis-
ease and “normality” are ill-defined. 
Sliding hiatal hernias favor GERD, especially if large, but
are not sufficient to provoke it: 80% of hiatal hernias are
not associated with GERD, but at least 20% of patients
affected with GERD do not have a hiatal hernia.
Only a minority of GERD patients have esophagitis,
which occurs mainly if total acid exposure is long, reflux-
es occur at night and have a long duration due to low
esophageal clearance.1 Symptoms are usually worse if
esophagitis is present, but one may have severe symp-
toms without esophagitis or esophagitis with no symp-
toms. Sometimes the first symptom is dysphagia caused
by stenosis-complicating esophagitis. Patients exist
whose symptoms are caused by refluxes that do not
exceed upper normality values at pH monitoring. As a
matter of fact, symptoms are caused either by patholog-
ical refluxes or by abnormal sensitivity of esophageal
mucosa, or by both. 
MATERIALS AND METHODS
From November 1991 to March 1999, 95 patients had a
total fundoplication (Rossetti’s procedure); 31 had a pos-
terior 180° fundoplication (Toupet’s procedure) because
preoperative manometry showed disordered motility of
the esophageal body (mean pressure lower than 30 mm
of mercury, more than 30% disordered contractions, or
both); 16 patients had an anterior 180° fundoplication
(Dor’s procedure); and 6 had a simple recontruction of
His’ angle. These minor antireflux procedures were
adopted to prevent GERD after Heller’s operation (10
patients) or surgery for paraesophageal hernia (4
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patients), or to correct a mild GERD (and normal HPZ at
preoperative manometry) in patients who needed laparo-
scopic cholecystectomy (3 patients). The preoperative
studies included esophago-gastric X-ray, endoscopy, 24
hours pH ambulatory monitoring, and manometry for
avoided esophageal disorders. In our experience, the
patients with Visick I-II equaled 97.3%.
THE DIAGNOSTIC FLOW CHART (Table 1)
Symptoms of GERD may be “typical” (but they are not
specific to GERD), that is, heartburn and regurgitations,
or atypical (ear, nose, or throat symptoms, asthma, non-
cardiac thoracic pain).
In case of “typical symptoms,” it is commonly agreed that
patients younger than 50, with a recent history of GERD
and no “alarm symptoms” (dysphagia, loss of weight,
hemorrhage, anemia) need no investigation before “ex
iuvantibus” medication. Alarm symptoms should alert
physicians to cancer or complications of esophagitis
(ulcer, stenosis). All other patients need endoscopy, as
do people who do not respond to medication. Atypical
symptoms require endoscopy to be indicated for GERD,
but if esophagitis is absent, a diagnosis needs manome-
try, too. Patients with typical symptoms and normal
endoscopy do not need 24 hours pH ambulatory moni-
toring unless they receive no benefit from medication. 
The “omeprazole test,” that is, proton pump inhibitors
(PPI) given for 2-4 weeks, is a useful tool for reinforcing
the GERD diagnosis. On the contrary, if symptoms are
not relieved by PPI, esophagitis is absent, and no signif-
icant temporal relationship exists between symptoms and
refluxes during pHmetry, even if total esophageal acid
exposure is increased, GERD might not be responsible
for symptoms. This is important because these patients
are usually referred for antireflux surgery.2
Typical Symptoms
⇓⇓
Recent, no alarm symptoms Old, alarm symptoms
⇓⇓
Ex adiuvantibus medication Endoscopy
⇓⇓⇓ ⇓
Benefit No Benefit Positive Negative
⇓⇓ ⇓
Endoscopy Medication Manometry
⇓⇓ ⇓ ⇓
Positive Negative Benefit No Benefit
⇓⇓
Manometry Manometry
Table 1.
Algorithm of GERD Diagnosis.
Atypical Symptoms
⇓
Endoscopy
⇓
Esophagitis
⇓⇓
Positive Negative
⇓⇓
GERD therapy Manometry
⇓⇓
Positive Negative
⇓
Omeprazole TestENDOSCOPY AND HISTOLOGY
Mucosal hyperemia should not be considered esophagi-
tis: first grade inflammation has at least 1 erosion. If no
mucosal breaks exist, histology is not useful for diagnos-
ing esophagitis. Confluent erosions characterize second
grade esophagitis; the third grade has circumferential
erosions, and stenosis, ulcer, or columnar metaplasia are
the stigmata of fourth grade inflammation.3
Histology is not needed if erosions are present, but it is
necessary in case of ulcer or stenosis, to exclude malig-
nancy, and when Barrett’s esophagus is suspected. This
clinical condition may not be confirmed or excluded by
endoscopy alone.4 A histology examination also looks
for dysplasia associated with Barrett’s mucosa. Three
months of proton pump inhibitor use is required to dif-
ferentiate dysplasia from histological changes due to
inflammation. Barrett’s esophagus has 10% risk of malig-
nant degeneration,5 but only if intestinal metaplasia is
present. This is possible also when the gastric lining does
not extend more than 3 centimeters above the esopha-
gogastric junction, as thought before. Even if only a small
area of metaplasia is found above the cardia and intes-
tinal metaplasia is present, we have an increased risk of
cancer (“short Barrett”). Vital stainings may be useful for
detecting metaplastic mucosa, dysplasia, and carcinoma.3
Endoscopy is important in choosing the appropriate treat-
ment for different groups of GERD patients (Table 2).
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Mild esophagitis is grade 1; severe is grade 2-3-4. All
grades of esophagitis require use of proton pump
inhibitors for at least 8-12 weeks, and ranitidine or pro-
kinetics, or both of these may be tried for GERD without
esophagitis, in association with life style changes, loss of
body weight, and correction of other risk factors.
Sometimes PPIs are required also for GERD without
esophagitis, if minor drugs are ineffective. Endoscopic
control is not necessary for all patients. If medication
succeeds in controlling symptoms, no endoscopic con-
trol is needed in patients with no esophagitis or grade 1
esophagitis, because mucosal healing is the rule and the
risk of complications is low. Endoscopic control is sug-
gested if symptoms persist and also in cases of severe
esophagitis even if symptoms have subsided, to check
mucosal healing.
The most severe esophagitis may be treated with drugs,
but surgery is often preferred, even if PPIs are probably
as effective as surgery in controlling symptoms and heal-
ing esophagitis. In fact, esophageal protection depends
on continuous regular lifelong compliance to drugs.
Before PPIs were introduced, surgery proved to be more
effective than anti-H2 therapy.6 Usually GERD is treated
with medication, but the role of surgery has increased
because minimally invasive procedures have proved to
be as effective as open surgery,7 and pain and postoper-
ative discomfort are minimal, recovery is fast, and hospi-
talization is very short. Great surgical expertise is
required though. The following are the precise surgical
indications: pharmacological treatment is ineffective;
compliance to medication is unsatisfactory; continuous
medication is needed in young people; regurgitations are
Table 2.
Relationship Between Esophagitis and Treatment.
Absent Mild Severe
⇓⇓⇓
minor drugs PPI PPI (surgery)
⇓⇓⇓
endoscopic control endoscopic control
only if medication
is ineffective 
⇓⇓
occasional or  long term treatment
intermittent treatment with PPI
(long-term if symptoms
recur immediately)
Table 3.
Treatment and Follow-up of Barrett’s Esophagus.
High risk surgical patients: no control
First histological control after three months of PPI
No dysplasia: histology every two years
Mild dysplasia: histology every year
Moderate dysplasia: histology every six months
Severe dysplasia: immediate control of dysplasia and 
esophagectomy if confirmed (endoscopic treatments for 
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the main symptom; a large hiatal hernia provokes
mechanical symptoms.
Continuous treatment is required if symptoms recur when
medication is interrupted and in case of severe esophagi-
tis. These last patients require PPIs. Long-term treatment
with PPIs may cause atrophic chronic gastritis if
Helicobacter pylori is not eradicated. If esophagitis is mild
or absent, long-term treatment with anti-H2 must be tried
before more powerful acid suppression is adopted. With
any drug, the rule is to prescribe the smallest effective
dose. Many patients whose symptoms relapse after a
period of remission require intermittent therapy, and usu-
ally anti-H2 is sufficient. Most patients with occasional
symptoms may be treated with antacids only when need-
ed.
Endoscopy and histology are also important in deciding
how to treat and control patients with Barrett’s mucosa
(Table 3).8
RADIOLOGY
An upper gastrointestinal (GI) series is recommended as
the first-line examination in cases of dysphagia to differ-
entiate organic from functional dysphagia. Small hiatal
hernias are revealed by X-rays better than by endoscopy.
Rotational or mixed hernias too are better evaluated by
X-rays and should be treated surgically to avoid their fre-
quent and severe complications. An upper GI series is
also recommended to any patient indicated for surgery in
the following situations: a hiatal hernia that is not self-
reducing in the standing position, in a patient with
severe long-standing esophagitis, suggesting brachye-
sophagus. It helps to differentiate GERD from other
esophageal diseases, like achalasia. 
pH MONITORING
Indications for 24-hour esophageal pH monitoring are
summarized in Table 4. Table 5 shows upper limit val-
ues.2 The most important parameters are total time and
the number of episodes longer than 5 minutes. If 1 of
them is abnormal, pH monitoring may be considered
positive.9 Severe esophagitis is usually associated with
severe reflux.
Twenty-four hours pH monitoring is also “positive” in
case a statistically significant relationship between reflux-
es and symptoms is revealed. Some patients have normal
values, but their symptoms occur during reflux episodes
or within 2 minutes. We may say that they have an “acid
hypersensitive esophagus.”2
Twenty-four hours pH monitoring is highly specific
(false-positives are rare) if the esophageal electrode is
correctly positioned 5 centimeters above the high pres-
sure zone (HPZ). Its sensitivity is only 70 to 80%, so a
negative examination does not exclude GERD. False-neg-
atives may be due to calibration, wrong electrode posi-
tioning, medication, or occasional normality during the
examination. Sensitivity is even lower (60 to 70%) in the
case of patients with negative endoscopy, that is, when
the test would be more useful.2
MANOMETRY
Indications for esophageal manometry are summarized
in Table 6. In case of functional dysphagia, this test dif-
ferentiates nonspecific motor disorders associated with
GERD from other esophageal motor disorders, aspecific
or specific (achalasia, diffuse esophageal spasm, hyper-
tensive lower esophageal sphincter). 
Performance of preoperative manometry is necessary for
deciding whether total fundoplication is possible. This
procedure is more efficacious than 180° or 270° wraps,
but requires efficient esophageal body motility. If disor-
Table 4.
Indications for Long-Term ph-Monitoring.
TO DIAGNOSE GERD: atypical symptoms with negative
endoscopy, typical symptoms resistant to medication 
PREOPERATIVE
SURGICAL FAILURES
Table 5.
pH-Monitoring: Cutoff Points.
Total time < pH 4: 5%
Upright time < pH 4: 8%
Supine time < pH 4: 3%
Number of reflux episodes: 50
Number of reflux episodes > 5’: 3dered contractions exceed 25% of the total, or their mean
pressure is lower than 30 mm Hg, 360° fundoplication is
contraindicated, because of the high risk of postoperative
persistent dysphagia. An example of such esophageal
body disorders is patients affected with sclerodermia.
These patients may have severe GERD needing surgery,
but their severely disordered esophageal motility con-
traindicates a total fundoplication. Transient dysphagia is
common after fundoplications, especially after a total
one. Floppy and short 360° wraps have reduced postop-
erative dysphagia, as short vessel ligation in the opinion
of some surgeons. In our experience, short vessel liga-
tion in rarely necessary to obtain a floppy wrap, and
postoperative dysphagia did not occur any more when
we started selecting patients for total or partial wraps
depending on their preoperative manometry. Intraoper-
ative manometry is not necessary for calibrating the wrap
in the experience of most surgeons.
GASTRIC SCINTIGRAPHY 
Gastric emptying delay is frequently associated with
GERD. In rare cases, it is due to a gastrointestinal
obstruction, which needs to be removed thus correcting
reflux, too. In the vast majority of cases, we find a func-
tional delay in gastric emptying, which is usually amelio-
rated by antireflux surgery.10 It is important to differenti-
ate these patients from those with delayed gastric emp-
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tying and no GERD, because an antireflux procedure
could worsen their symptoms due to postoperative
inability to belch and vomit.
Gastric scintigraphy may be helpful for an accurate func-
tional evaluation of patients, but it is poorly standard-
ized, so that at the moment its practical value is not high. 
DIAGNOSIS OF ANTIREFLUX FAILURES
Currently the gold-standard surgical treatment for GERD
is laparoscopic fundoplication, either a 360° (Nissen,
Rossetti) or a 180-270° posterior wrap (Toupet, Lindt).
Failures of antireflux surgery may be classified as in
Table 7. The third group (“persistent symptoms unrelat-
ed to GERD”) includes patients whose symptoms were
not due to reflux, so that they persist or worsen after
antireflux surgery. In any case, the cause of failures is
either a wrong indication (“wrong patient”), a wrong
procedure even if well done (“wrong procedure”), or a
wrong technique (the patient had a correct surgical indi-
cation, the right procedure was chosen, but a faulty tech-
nique was performed). 
Persistent reflux is due to an inappropriate procedure or
wrong technique. For example, reconstruction of His’
angle and the Dor’s procedure may not be sufficient to
prevent pathological refluxes. Examples of wrong tech-
niques are disruption of a fundoplication due to
absorbable sutures, or sutures under tension, or its slip-
ping because of inadequate esophageal mobilization.
Early postoperative reflux is caused by a wrong tech-
nique; late reflux is usually due to unavoidable tissue
modifications. Diagnosis of persistent or recurrent GERD
is usually easy. An upper GI series may reveal upwards
migration of the repair (which is usually asymptomatic,
but may cause reflux or obstructional dysphagia).
Endoscopy may show esophagitis or the absence of the
wrap, which is normally evident with the scope in
retroflexed position. Twenty-four hours pH monitoring
reveals abnormal refluxes, and manometry may show a
low value of the high pressure zone (pressure, or length,
or both). 
Dysphagia is the most important side effect, the “gas
bloat syndrome” the most frequent. They are caused by
a wrap that hampers esophageal emptying, or belching,
or both, and vomiting. The first diagnostic test for post-
operative persistent dysphagia (when the cause is not
already clear to the surgeon who performed the proce-
Table 6.
Indications for Manometry.
FUNCTIONAL DYSPHAGIA
NONCARDIAC CHEST PAIN
GERD: preoperative
failures of antireflux surgery
Table 7.
Failures of Antireflux Surgery.
REFLUX: persistent or relapsing
SIDE EFFECTS: dysphagia, gas bloating, others
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dure just by recalling it) is radiology, which usually
shows slow esophageal emptying and some degree of
dilation, may reveal a slipped wrap, mediastinal hernia-
tion of the wrap, para-esophageal herniation,11 or a wrap
that was erroneously done with the anterior wall of gas-
tric body rather than the fundus. Endoscopy usually does
not add valuable information. Postoperative manometry
may be important. It may show a high-pressure zone with
abnormally high values (> 40 mm Hg, or > 3 cm, or
both). Postoperative manometric values are always high
compared with normal values, but they are reduced by
50% one year after the operation: that is why normal
early postoperative values of the lower esophageal
sphincter are 20 to 40 mm Hg. Abnormally high values
are caused by a wrap that is too long, too tight, or both
too long and too high, or by mediastinal migration of the
wrap that may compress the esophagus above it. In 1 of
our patients, manometry revealed a 5-cm long, 30 mm Hg
HPZ (too long, not too tight). 
Relaparoscopy showed that fundoplication was done
with the gastric body. Manometry may also show normal
values of the newly established high-pressure zone, but
abnormal motility of the esophageal body, which was
decompensated by a total fundoplication. Sometimes
manometry reveals a specific esophageal motor disorder
(achalasia for instance) that was not diagnosed preoper-
atively. This is 1 of the reasons why manometry should
always be performed before antireflux surgery. A certain
degree of incomplete relaxation of the newly created
HPZ is common, and sometimes it causes dysphagia. De
Meester12 believes it is due to poor mobilization of the
fundus. Finally, postoperative manometry may be nor-
mal. In these cases, it is not rare that also other tests did
not show any abnormality so that only relaparoscopy
reveals the cause of dysphagia: distorsion due to creation
of the wrap with the body rather than the gastric fundus,
a tight hiatusplasty, or stenosis of the esophageal hiatus
due to postoperative scarring, which Watson and
Jamieson11 described as a specific complication of laparo-
scopic fundoplication together with para-esophageal her-
niation.
Postoperative persistent dysphagia is usually treated by
endoscopic dilation at first, independently from the
cause. In case of failure, relaparoscopy is usually per-
formed. The surgical options are the following: a) redo
total wrap if it was too long or too tight (use a 60 French
bougie for calibration), or it was done with the gastric
body; b) transformation of a total fundoplication to a
posterior one (this can be easily done with an endo-GIA)
in case of disordered esophageal body motility;13 c)
transformation to a Heller-Dor’s procedure in case of
achalasia.13,14
CONCLUSIONS
Gastroesophageal reflux is a very common disorder.
Typical symptoms are heartburn, regurgitation and chest
pain. Recently, it has been demonstrated that gastroe-
sophageal reflux may generate or worsen extrae-
sophageal symptoms such as asthma, chronic bronchitis,
posterior laryngitis, and chronic cough. The diagnosis of
gastroesophageal reflux is suggested by typical symp-
toms which improve under a therapy with proton pump
inhibitors. pH monitoring over 24 hours is able to estab-
lish directly the diagnosis by measuring acid reflux into
the esophagus. Manometry detects the two most com-
mon causes of gastroesophageal reflux: insufficiency of
the lower esophageal sphincter or esophageal motility
abnormalities. Gastroesophageal reflux can lead to reflux
esophagitis, which is diagnosed endoscopically. An
endoscopy should routinely be performed in case of dys-
phagia, anemia or loss of weight. A long-term sequela of
gastroesophageal reflux is the development of Barrett’s
esophagus, a condition which has to be verified by
endoscopy and biopsy. This premalignant lesion is
defined by a metaplastic change from the normal squa-
mous mucosa to a specialized intestinal epithelium char-
acterized by goblet cells. Because dysplasia in these
metaplastic areas can lead to esophageal adenocarcino-
ma, regular endoscopic surveillance with biopsies is rec-
ommended. Gastroesophageal reflux can significantly
impair the quality of life and can cause complications
that include the neoplastic progression from Barrett’s
esophagus to carcinoma. Therefore, appropriate diag-
nostic procedures and adequate therapy are required. 
Prior to the advent of proton pump inhibitors, internists
recommended antireflux surgery primarily for patients
whose gastroesophageal reflux disease (GERD) failed to
respond to medical therapy. Although many physicians
still cling to the notion that antireflux surgery is a proce-
dure best reserved for “medical failures,” today this posi-
tion is inappropriate. Modern medical treatments for
GERD are extraordinarily effective in healing reflux
esophagitis. It is uncommon to encounter patients with
heartburn or esophagitis due to GERD who do notrespond to aggressive antisecretory therapy. Indeed, the
very diagnosis of GERD must be questioned for patients
whose esophageal signs and symptoms are unaffected by
the administration of proton pump inhibitors in high
dosages. In the large majority of these so-called refracto-
ry patients, protracted esophageal pH monitoring reveals
good control of acid reflux by the proton pump
inhibitors. This finding indicates that the persistent symp-
toms usually are not due to acid reflux, but to other
problems such as functional bowel disorders. Medical
treatment fails in such patients because the diagnosis is
mistaken, not because the drugs fail to control acid
reflux. Modern antireflux surgery also is highly effective
for controlling acid reflux, but fundoplication will not be
effective for relieving symptoms in patients whose symp-
toms are not reflux-induced. Therefore, many patients
deemed failures of modern medical therapy would be
surgical failures as well. Antireflux surgery is an excellent
treatment option for patients with documented GERD
who respond well to medical therapy, but who wish to
avoid the expense, inconvenience, and the theoretical
risks associated with lifelong medical treatment.
Ironically, surgical therapy for GERD today is best
reserved for patients who are medical successes.
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